SUMMARY N 6 -methyladenosine (m 6 A) regulates mRNA metabolism and translation, serving as an important source of post-transcriptional regulation. To date, the functional consequences of m 6 A deficiency within the adult brain have not been determined. To achieve m 6 A deficiency, we deleted Mettl14, an essential component of the m 6 A methyltransferase complex, in two related yet discrete mouse neuronal populations: striatonigral and striatopallidal. Mettl14 deletion reduced striatal m 6 A levels without altering cell numbers or morphology. Transcriptome-wide profiling of m 6 A-modified mRNAs in Mettl14-deleted striatum revealed downregulation of similar striatal mRNAs encoding neuron-and synapse-specific proteins in both neuronal types, but striatonigral and striatopallidal identity genes were uniquely downregulated in each respective manipulation. Upregulated mRNA species encoded non-neuron-specific proteins. These changes increased neuronal excitability, reduced spike frequency adaptation, and profoundly impaired striatal-mediated behaviors. Using viral-mediated, neuron-specific striatal Mettl14 deletion in adult mice, we further confirmed the significance of m 6 A in maintaining normal striatal function in the adult mouse.
INTRODUCTION
The discovery of reversible A tagging) has revealed an important layer of post-transcriptional gene regulation (Meyer and Jaffrey, 2014; Zhao et al., 2017) . m 6 A tagging affects almost every aspect of mRNA metabolism including splicing, export, localization, translation efficiency, and stability (Liu et al., 2014; Wang et al., 2014 Wang et al., , 2015 . Recent studies have shown that constitutive knockout of Mettl14, a key element of the m 6 A methyltransferase complex (Liu et al., 2014) , is embryonic lethal while conditional knockout of Mettl14 in neural progenitor cells disrupts cortical development and leads to premature death in mice (Yoon et al., 2017; Wang et al., 2018) . Because m 6 A levels in mouse brain tissue are relatively low through embryogenesis but drastically increase by adulthood (Meyer et al., 2012) , it remains possible that m 6 A tagging plays a unique role in the adult brain. Indeed, studies examining the consequences of Fto manipulation, an m 6 A demethylase (Jia et al., 2011) , suggest that m 6 A tagging plays an important role in learning and behavior (Hess et al., 2013; Walters et al., 2017; Widagdo et al., 2016) . However, Fto has functions aside from m 6 A demethylation (Jia et al., 2008; Mauer et al., 2017) , and Fto encodes only one of two known m 6 A demethylases (Zheng et al., 2013) . Thus, the functional consequences of Fto manipulations could arise from causes other than changes in m 6 A tagging. Using cell-type-specific genetic deletion or brain-region-specific adeno-associated virus (AAV)-mediated deletion of Mettl14, here we study the necessity of m 6 A tagging in neurons by examining the functional consequences of m 6 A loss in the adult mammalian brain.
RESULTS

Conditional Deletion of Mettl14 in Striatonigral and Striatopallidal Neurons Decreases m 6
A Methylation and Alters mRNA Expression To bypass the detrimental effects of Mettl14 deletion in early embryonic development (Yoon et al., 2017; Wang et al., 2018) , we crossed mice carrying a conditionally removable allele of Mettl14 (M14 f/f ) with mice expressing Cre recombinase under control of either the dopamine D1 receptor (D1R) promoter (D1R-fM14exp) or ADORA2A promoter (D2R-fM14exp) to delete Mettl14 in dopamine D1R-expressing striatonigral neurons or dopamine D2 receptor (D2R)-expressing striatopallidal neurons, respectively. These cells represent the two prominent striatal projection neuron types with roughly even distribution throughout the striatum. Both D1R-and D2R-fM14exp mice were viable. Adult mutant mice (2-6 months old) were not obviously distinguishable from littermate controls (referred herein as D1R-fM14ctrl and D2R-fM14ctrl), although motor impairments became more obvious in older mice.
Deletion of either striatonigral or striatopallidal Mettl14 significantly decreased striatal cells double-labeled for both NeuN and (legend continued on next page) METTL14 (D1R, t = 7.608, p = 0.0032; D2R, t = 3.2092, p = 0.0326), without affecting overall levels of NeuN in either manipulation (Figures S1A and S1B; D1R, t = À0.1079, p = 0.9197; D2R, t = 0.3825, p = 0.7216). We also found intact striatonigral projections to the substantia nigra pars reticulata in D1R-fM14exp mice ( Figure S1C ) and intact striatopallidal projections to the globus pallidus in D2R-fM14exp mice ( Figure S1C ). m 6 A mRNA immunoprecipitation followed by RNA sequencing (m 6 A-seq) revealed more than 33,500 putative m 6 A sites enriched in more than 11,000 mRNA species in control striatum, with a transcriptome-wide distribution and preferred consensus motif similar to previous reports (Meyer et al., 2012; Liu et al., 2014; Figures 1A and 1B) . Mettl14 deletion in either cross significantly reduced overall m 6 A levels determined by liquid chromatography-tandem mass spectrometry (LC-MS/MS) ( Figure 1C ; D1R, t = 18.34, p < 0.0001; D2R, t = 4.402, p = 0.0033). Loss of striatonigral Mettl14 resulted in the downregulation of 740 m 6 A-containing mRNAs ( Figures 1D and 1F ) and upregulation of 498 m 6 A-containing mRNAs ( Figures 1D and 1H ). The magnitude of change in both downregulated ( Figure 1F ; t = 3.6157, p = 0.0003) and upregulated ( Figure 1H ; t = 2.288, p = 0.0225) mRNAs positively correlated with magnitude of decrease in m 6 A peak enrichment in D1R-fM14exp mice (Table S1 ), meaning that transcripts with the largest decrease in m 6
A mRNA enrichment score in experimental mice relative to control mice also showed the greatest degree of change in mRNAs (either up or down).
In D2R-fM14exp mice, we similarly found a greater number of downregulated m 6 A-containing mRNAs (Figures 1E and 1F ; n = 433) than upregulated m 6 A mRNA species (Figures 1E and 1H; n = 180) . Similar to D1R-fM14exp mice, the degree of downregulation of mRNA species correlated with loss of m 6 A enrichment ( Figure 1F ; t = 2.1575, p = 0.03151). However, we found no significant correlation between upregulation of mRNA species and m 6 A enrichment ( Figure 1H ; t = 1.2007, p = 0.2314; Table S1 ). Gene ontology (GO) analyses revealed that genes associated with downregulated mRNAs containing m 6 A sites were enriched in neuron-specific compartments including the synapse, postsynaptic membrane, axon, and dendrites in both D1R-and D2R-fM14exp mice ( Figure 1G ). Moreover, we found downregulation of striatal mRNAs containing m 6 A sites in numerous genes important for synaptic plasticity, including Homer1 and Cdk5r1, in both D1R-and D2R-fM14exp mice. Despite these shared changes in mRNAs encoding neuronal and synaptic proteins, only D1R-fM14exp mice showed significantly reduced expression of striatonigral identity genes encoding the precursors of substance-P (Tac1, t = 3.806, p = 0.0190) and dynorphin (Pdyn, t = 5.288, p = 0.0061). Likewise, only D2R-fM14exp mice showed decreased mRNA expression of the striatopallidal identity genes for the enkephalin precursor (Penk, t = 7.162, p = 0.0029) and D2R (Drd2, t = 3.389, p = 0.02805). All of these identity genes contain m 6 A consensus sequences. In contrast, GO analyses of genes containing m 6 A sites that resulted in upregulation of striatal mRNA expression in D1R-fM14exp mice revealed enrichment primarily in metabolism, ribosomal machinery, and translation ( Figure 1I ). In D2R-fM14exp mice, we found almost no significant enrichment terms when upregulated mRNA species were subjected to GO analysis ( Figure 1I ). Subsequent analysis revealed a subset of 86 genes ( Figure 1J ) downregulated in both D1R-and D2R-fM14exp mice with GO enrichment in membrane, axon, and phosphoproteins (Figure 1K) , while 47 genes were upregulated in both D1R-and D2R-fM14exp mice. Importantly, only three genes with significant changes in mRNA expression in both D1R-and D2R-fM14exp mice showed altered expression in opposite directions (e.g., upregulated in D1R-fM14exp, but downregulated in D2R-fM14exp mice), suggesting lack of Mettl14 alters mRNA expression in these two neural populations similarly.
Striatonigral and Striatopallidal Mettl14 Deletion Impairs Striatal-Mediated Performance and Learning
To examine the behavioral consequences of Mettl14 deletion, we focused on well-established striatum-dependent behaviors, which require intact cortico-striato-thalamic circuitry. We used the accelerating rotarod to assess sensorimotor learning and the water cross maze to assess response-reversal learning. Impairments were observed in sensorimotor learning (D1R, Figure 2A ; genotype main effect, F (1,52) = 10.22, p = 0.0070; D2R, Figure 2B ; genotype main effect, F (1,120) = 4.615, p = 0.0227) and reversal learning (Figure 2C , right; D1R, log-rank MantelCox, chi-square = 9.356, p = 0.0022; D2R, log-rank MantelCox, chi-square = 3.704, p = 0.0543) in both D1R-and D2R-fM14exp mice, while initial acquisition of response learning See also Figure S1 and Table S1 .
was normal (Figure 2C , left; D1R, log-rank Mantel-Cox, chisquare = 0.004413, p = 0.8336; D2R, log-rank Mantel-Cox, chi-square = 0.8056, p = 0.3694). Gross motor performance was then assessed using a visible platform task. We found significantly increased latency to reach the platform in mice with striatonigral (Figure 2D , left; t = À6.421, p = 0.0016), but not (C) Response learning acquisition (left) and reversal learning (right) in mice with Mettl14 deleted in striatonigral (top) and striatopallidal (bottom) neurons using the water cross maze. Survival plots show percent mice remaining below learning criterion. D1R-fM14exp, n = 6; D1R-fM14ctrl, n = 5; D2R-fM14exp, n = 6; D2R-fM14ctrl, n = 7. (D) Latency to reach a visible platform in the water maze for entire session (top) and across five trials (bottom). Left: D1R-fM14exp, n = 6; D1R-fM14ctrl, n = 5. Right: D2R-fM14exp, n = 6; D2R-fM14ctrl, n = 7. (E) Locomotor response of D1R-fM14exp and control mice to a single injection of the D1R agonist SKF82197 (8.0 mg/kg) across 1 min bins (bottom). Total ambulatory distance across 60 min (top, left) and percent (%) change in locomotion following SKF81297 injection relative to saline (top, right). D1R-fM14exp, n = 8; D1R-fM14ctrl, n = 7.
(F) Locomotor response of D2R-fM14exp and control mice to a single injection of the D2R antagonist eticlopride (0.16 mg/kg) across 1 min bins (bottom). Total ambulatory distance across 60 min (top, left) and percent (%) change in locomotion following eticlopride injection relative to saline (top, right). D2R-fM14exp, n = 14; D2R-fM14ctrl, n = 17. All data expressed as mean ± SEM. striatopallidal ( Figure 2D , right; t = À0.8932, p = 0.3901), Mettl14 deletion.
Striatonigral and Striatopallidal Mettl14 Deletion Increases Sensitivity to Dopaminergic Drugs
We next administered pathway-specific drugs to evaluate locomotor responsivity. Baseline locomotor activity did not differ in either D1R-fM14exp ( Figure 2E ; genotype, F (1.767) = 0.0725, p = 0.7920; genotype 3 time interaction, F (59,767) = 0.9441, p = 0.5963) or D2R-fM14exp mice ( Figure 2F ; genotype, F (1.1711) = 2.970, p = 0.955; genotype 3 time interaction, F (59,1711) = 0.1.326, p = 0.0512), though there was a trend toward hyperactivity in D2R-fM14exp mice. D1R-fM14exp mice showed significantly increased sensitivity to the selective D1R agonist SKF-81297 ( Figure 2E ; genotype 3 drug, F (1,13) = 7.029, p = 0.0200). In contrast, D2R-fM14exp mice showed almost normal sensitivity to the selective D2R antagonist eticlopride ( Figure 2F ; genotype 3 drug, F (1,28) = 0.0400, p = 0.8430). We chose to treat D2R-fM14exp mice with an antagonist rather than an agonist due to a potential confound arising from D2R agonist activation of D2 autoreceptors, which dramatically reduce dopamine release.
Morphology of Striatonigral Neurons Is Normal following Mettl14 Deletion
The epitranscriptomic and behavioral analyses suggest that Mettl14 deletion from specific neuronal populations alters neuronal function. To study how neuron-specific Mettl14 deletion may alter neuronal structure and function, we first examined basic morphological properties in the striatonigral pathway of D1R-fM14exp mice. We focused on the striatonigral-specific deletion as we observed a more severe phenotype in these mice. To visualize dendritic spine morphology in D1R neurons (Figure 3 ), we injected an AAV encoding Cre-dependent mCherry into the dorsal striatum of adult D1R-fM14exp and M14 f/À ;D1Rcre + control (D1R-fM14ctrl) mice. Immunohistochemistry revealed a lack of METTL14 in mCherry-positive striatal cells in D1R-fM14exp mice ( Figure 3A ). We found no difference in dendritic branching ( Figure 3B ); dendritic diameter ( Figures 3C and 3D) ; total spine number ( Figures 3C and 3E) ; or number or volume of stubby, mushroom, and thin dendritic spines (Figures 3F and 3G; see Table S2 for statistics).
Deletion of Mettl14 in Striatonigral Neurons Alters Neuronal Excitability
To determine if Mettl14 deletion alters intrinsic physiological properties of striatonigral neurons, we performed whole-cell recordings in mCherry-labeled D1 neurons. Recorded cells were filled with biocytin to confirm lack of METTL14 ( Figure 3H ). We found no difference in passive membrane properties (Figures  3I-3K; Table S2 ), including resting membrane potential, input resistance, and capacitance. However, a leftward shift in the current-voltage relationship, while not significant, was observed in D1R-fM14exp mice ( Figure 3N ). Striatonigral Mettl14 deletion also significantly lowered the current threshold to generate both a single action potential (rheobase; Figure 3L ) and a train of action potentials ( Figure 3O , inset), suggesting Mettl14 deletion increases neuronal excitability. Interestingly, instantaneous firing frequency did not differ ( Figure 3O ), yet the number of spikes at a given frequency was significantly lower in D1R-fM14exp mice ( Figure 3P ), suggesting Mettl14 deletion alters spike frequency adaptation. These differences are likely due to altered intrinsic striatonigral signaling rather than inputs to striatonigral neurons as we found no difference in paired pulse ratio ( Figure 3M ).
Viral-Mediated Deletion of Mettl14 in Adult Striatal
Neurons Reduces m 6 A Methylation, Impairs Striatal Learning, and Alters Dopamine Signaling Because D1Rcre and A2ARcre direct Cre expression starting in late embryonic development (Sillivan and Konradi, 2011; Weaver, 1993) , data collected with these mouse lines may include developmental effects of Mettl14 deletion. To strictly test the necessity of Mettl14 in adult neurons, we injected an AAV encoding Cre or eGFP under control of the synapsin promoter (Syn-Cre or Syn-eGFP) bilaterally into the dorsal striatum of adult M14 f/f mice. Viral-mediated Mettl14 deletion resulted in a substantial loss of METTL14 protein ( Figure 4A ) and reduced striatal m 6 A levels ( Figure Table S1 ). Lack of significance may be due to a loss in signal to noise stemming from the inclusion of striatal cells outside the injection site. Moreover, the striatal network may not sufficiently adapt after only a few weeks of m 6 A deficiency. Analysis of striatal-mediated behaviors showed Syn-cre mice were impaired in sensorimotor learning ( Figure 4C ; 4 weeks post-injection, AAV effect, F (1,9) = 5.016, p = 0.0390; 8 weeks post-injection, F (1,64) = 7.639, p = 0.0136) as well as both initial acquisition of response learning ( Figure 4D ; log-rank MantelCox, chi-square = 9.158, p = 0.025) and reversal learning (Figure 4D ; log-rank Mantel-Cox, chi-square = 14.51, p = 0.0001). Strikingly, not a single Syn-Cre mouse completed reversal training. A visible platform test revealed that Syn-Cre mice were overall slower to reach the escape platform, though this difference disappeared by the last trial ( Figure 4E ; F (1,56) = 5.227, p = 0.0383).
We next assessed the effects of Mettl14 viral deletion on locomotor response to a D1R agonist or D2R antagonist. We found no difference in baseline ambulatory distance ( Figure 4F ; F (1,826) = 0.6530, p = 0.4362; Figure 4G ; F (1,826) = 0.05255, p = 0.8220). Syn-Cre mice showed a significant increase in locomotor response to the D1R agonist ( Figure 4F ; virus 3 drug, F (1,16) = 11.54, p = 0.000368) and a minor increase in response to the D2R antagonist ( Figure 4G ; virus 3 drug, F (1,14) = 3.091, p = 0.1010).
DISCUSSION
Brain epitranscriptomics is an emerging concept. Among posttranscriptional modifications, m 6 A methylation is the most In the current study, we focused on the adult striatum for two reasons. First, its functional role in motor learning is well established. Second, there are two prominent and largely discrete neuronal cell types throughout the striatum-striatonigral and striatopallidal-with only a few genes differentiating identity and function. Not too surprisingly, Mettl14 deletion in either subtype led to changes in similar classes of mRNA species. While the fate of m 6 A-tagged mRNAs (i.e., degradation or increased ribosomal loading) depends on the binding of specific m 6 A reader proteins (Wang et al., 2014 (Wang et al., , 2015 Shi et al., 2017) , it is remarkable that we observed a clear split in which downregulated mRNAs primarily encoded neuron-and synapse-specific proteins, and upregulated mRNAs primarily encoded globally expressed proteins involved in metabolism and translational regulation. Furthermore, it is intriguing that several mRNAs encoding striatonigral identity genes (e.g., Tac1 and Pdyn) were uniquely downregulated following striatonigral Mettl14 deletion, while striatopallidal identity genes (e.g., Penk and Drd2) were uniquely downregulated following striatopallidal Mettl14 deletion. Notably, we found no difference in overall striatal cell numbers or axonal projections in either manipulation, and dendritic morphology was normal following striatonigral Mettl14 deletion. These results suggest that Mettl14, and by extension m 6 A tagging, could play an important role in maintaining identity of discrete neuronal populations in adult mice.
The striatum acts to filter cortical inputs, with the striatonigral and striatopallidal pathways working in concert to promote some actions while inhibiting others (Lerner and Kreitzer, 2011) . Thus, disruption to either striatonigral or striatopallidal neuron properties (e.g., downreguation of various ion channels) could have profound consequences. Functionally, we found increased neuronal excitability in Mettl14-deficient striatonigral neurons, yet prolonged stimulation impaired spike frequency adaptation. We speculate that such impairment (Venance and Glowinski, 2003; Ha and Cheong, 2017) may profoundly impact the ability of striatonigral neurons to properly integrate cortical inputs and faithfully respond to the increased activity demands that accompany learning. However, whether specific genes contribute to this phenomenon and whether such a phenomenon translates across other neural subtypes (e.g., glutamatergic projection neurons or interneurons) remain to be determined.
Behaviorally, we observed impaired striatal-dependent behaviors among all three manipulations to varying extents. Mettl14 deletion in D1 neurons resulted in a more severe phenotype than Mettl14 deletion in A2A neurons. This effect may be specific to the affected pathway. Another possible explanation is that D1R, while mostly expressed in striatonigral neurons, is also expressed in some cortical neurons, whereas A2AR expression is more restricted to striatopallidal neurons. Notably, we found the most severe impairments in initial acquisition of response learning and reversal learning following pan-neuronal, viral-mediated Mettl14 deletion in the adult brain, when Mettl14 deletion was most pervasive.
The present study has provided the first direct and specific evidence that m 6 A deficiency in a subset of neurons in the adult brain impairs learning and performance. Axon pCLAMP v10.6.2.2 Molecular Devices http://mdc.custhelp.com/app/answers/detail/ a_id/18779/$/axon%E2%84%A2-pclamp%E2%84%A2-10-electrophysiologydata-acquisition-%26-analysis-software
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
General animal information
For all studies, male and female mice aged 2-8 months on a C57BL/J background were used. Mice were housed in standard conditions on a 12 h light/dark cycle in a temperature-and humidity-controlled barrier facility and allowed ad libitum access to standard chow and water. Behavioral testing occurred during the light phase. All procedures were in accordance with guidelines of and approved by the Institutional Animal Care and Use Committee at the University of Chicago.
Conditional Mettl14 deletion
Mice with a conditionally removable Mettl14 allele (Yoon et al., 2017; Weng et al., 2018) were crossed to a dopamine 1 receptor (D1R) promoter-driven Cre recombinase transgenic line (B6.FVB(Cg)-Tg(Drd1-cre)EY262Gsat/Mmucd, RRID: MMRRC-030989-UCD) to conditionally delete Mettl14 from striatonigral neurons, or an adenosinse 2A receptor (A2AR) promoter-driven Cre recombinase line (B6.FVB(Cg)-Tg(Adora2a-cre)KG139Gsat/Mmucd, RRID: MMRRC_036158-UCD) to delete Mettl14 from striatopallidal neurons. All experiments performed used double transgenic mice and respective littermate controls. A subset of mice homozygote for the floxed Mettl14 gene (M14 f/f ) were virally injected with an adeno-associated virus (see below).
METHOD DETAILS Viral Injection
Drug and behavior naive male ($25.0 g) and female ($20.0 g) M14 f/f mice aged 8-12 weeks were anesthetized using 2% isofluorane and placed in a stereotaxic frame. Under sterile conditions, the skull of each mouse was exposed and bregma identified. For viral Mettl14 deletion studies, three bilateral bur holes drilled above the dorsal striatum (AP: +1.1 mm, ML: ± 1.5 mm; AP: +1.1 mm, ML: ± 2.0 mm; AP: +0.5 mm, ML: ± 2.0 mm). a guide needle was lowered $2.7 mm DV into each site relative to the skull surface. 200 nL of an AAV-virus with Cre-recombinase (University of Pennsylvania Vector Core, AAV1.hSyn.Cre.WPRE.hGH,) or eGFP (University of Pennsylvania Vector Core, AAV1.hSyn.eGFP.WPRE.bGH) directed by the synapsin promoter was delivered at a rate of 100 nl/min, and the virus was allowed to diffuse for 7 min post-injection before needle extraction. For mCherry studies (University of North Caroline Vector Core, AAV2-EF1a-DIO-mCherry), the same procedure as above was followed except only one hole bilaterally (AP:0.8, ML: ± 1.7, DV: À2.7) was drilled and only 100 nL of virus was delivered.
Drugs SKF-82197 (Sigma-Aldrich, St. Louis, MO) and eticlopride (Sigma-Aldrich, St. Louis, MO) were used in open field studies. All drugs were dissolved in 0.9% sterile saline, and all injections were intraperitoneal (i.p.) at 0.01 ml/g of body weight.
Rotarod
The accelerating rotarod was used to assess sensorimotor learning as described previously (Beeler et al., 2012; Koranda et al., 2016) . Briefly, a computer-controlled rotarod apparatus (Rotamex-5, Columbus Instruments, Columbus, OH, USA) with a rat rod (7 cm diameter) was set to accelerate from 4 to 40 revolutions per minute (rpm) over 300 s, and time to fall was recorded. Mice received five consecutive trials per session, one session per day with approximately 30 s intertrial intervals (ITI). All groups of mice received rotarod training at approximately 3 months of age as a high pass filter to verify phenotype.
Visible Platform Test
A white acrylic pool 100 cm diameter (Med Associates, St. Albans, VT) was filled so that the water line was approximately 15 cm below the lip of the pool. Water was maintained between 22 and 24 C. Non-toxic white paint (Reeves and Poole Group, Toronto, Canada) was stirred in and a circular escape platform (diameter 8 cm, Med Associated, St. Albins, VT) was submerged $0.5 cm below the water surface with a blue flag attached above the water surface. Mice were initially placed on the platform for 15 s. Five subsequent trials were run with the platform moved to a new location at each trial. If the mice did not find the platform within 120 s, the trial was terminated and the mouse was put on the platform for 15 s and then placed under a heat lamp for 30 s before beginning the next trial. The five trials for each mouse were averaged to yield a single visible platform latency measure and a Student's t test was performed.
Water Cross Maze
Mice were trained in the water cross maze as described previously (Kheirbek et al., 2009) . Briefly, experiments were conducted in the above water tank with white plexiglass walls (University of Chicago, Machine Shop) inserted in the tank to make alleyways. The same escape platform used in the visible platform task was submerged with no visible markers. A black curtain surrounded the maze to reduce spatial cues. A trial was started by placing a mouse in the start arm facing the wall of the tank. Once the mouse made a right or left turn out of the start arm, a divider closed off the arm and the mouse was either allowed to stand on the platform for 15 s or explore the arm of the maze without the platform for 15 s. Mice were then removed from the maze and placed under a heat lamp for 30 s before beginning the next trial. Trials were started randomly from either the north or the south end of the maze with the goal arm always to the right of the start arm during initial response acquisition and to the left of the start arm during reversal learning. Correct or incorrect choices were recorded, and the walls of the maze were rotated every ten trials to reduce inter-maze cues. For each phase, criterion was reached once a mouse completed 8 out of 10 trials correctly for 3 consecutive days. For the viral-mediated deletion study, mice that did not reach acquisition criteria by 35 days were removed from the study and 35 days was recorded for statistical purposes. Similarly, for the conditional Mettl14 studies, mice that did not complete reversal in twice the amount of time it took them to complete acquisition were discontinued from the study and records reflected the last day of participating in the experiment. All measurements were made using a live camera and EthoVision (Noldus) software. A log-rank, Mantel-Cox test was used to determine significance.
Open Field
Open field chambers were 40 3 40 cm (Med Associates, St. Albans, VT, USA) with lighting at 21 lux. Each chamber was surrounded by black drop cloth obscuring views beyond the chamber. Infrared beams recorded the animals' locomotor activity. Data were collected in 1 min bins during each session. All drugs were administered immediately prior to mice being placed in the open field.
Immunohistochemistry
Brain tissues were fixed with 4% formaldehyde at various time points post-injection as described in the results and figure legends. Brains were transferred into 30% sucrose for 24 hr, and then 40 mm coronal serial brain sections were made using a cryostat (Leica Instruments). Prior to immunostaining for METTL14, slices underwent an epitope retrieval protocol where slices were treated for 30 min with a buffer containing 10 mM sodium citrate, pH 9 in tris buffer saline (TBS). This step was skipped for immunohistochemistry not requiring anti-METTL14. Sections were blocked in TBS containing 5% normal donkey serum and 0.3% Triton X-100 for 1 h at room temperature, transferred to primary antibody containing 0.3% Triton X-100 with 1% BSA, and incubated at 4 C for 72 hr. Antibodies used include: mouse monoclonal anti-NeuN (1:250, EDM Millipore Cat# MAB377, RRID: AB_2298772), rabbit polyclonal anti-ENKEPHALIN (ImmunoStar Cat#20065, RRID: AB_572250) and rabbit monoclonal anti-METTL14 (1:200, Sigma-Aldrich Cat# HPA038002, RRID: AB_10672401). Secondary antibodies (Life Technology Invitrogen) were diluted in 5% normal serum at 1:500 for 1 hr at room temperature.
Fluorescent microscopy
Images to confirm METTL14 deletion in D1R and A2AR cross as well as viral deletion were captured with an Olympus IX81 inverted epiflurorescence microscope with the Olympus Zero Drift Correction auto re-focusing system (Olympus Corporation of the Americas, Center Valley, PA) with a Hamamatsu Orca Flash 4.0 sCMOS camera (Hamamatsu Photonics, Skokie, IL) run by Slidebook 5.0 software (Intelligent Imaging Innovations, Denver, CO). Images were captured at 10x or 60x. Fluorescent intensity and cell counting were performed and analyzed using a minimum of 3 striatal slices from each individual mouse in FIJI (Schindelin et al., 2012) .
LC-MS/MS
Levels of total m 6 A in the striatum were quantified by liquid chromatography-tandem mass spectrometry (LC-MS/MS). Striata were dissected out from fresh tissue and total RNA was isolated with TRIzol reagent (Invitrogen) using an RNeasy lipid tissue mini-prep (QIAGEN). mRNA was further purified using Dynabeads mRNA purification kit and column (Invitrogen). After the addition of NH4HCO3 and alkaline phosphatase and an additional incubation of 2 h at 37 C, the samples were diluted to 60 ml and filtered (Millipore), and 10 ml of each sample was injected into LC-MS/MS. Nucleosides were separated by reverse phase ultra-performance liquid chromatography on a C18 column with on-line mass spectrometry detection using an Agilent 6410 QQQ triple-quadrupole LC mass spectrometer in positive electrospray ionization mode. The nucleosides were quantified by using the nucleoside to base ion mass transitions of 282 to 150 (for m 6 A), and 268 to 136 (for A). Quantification was performed in comparison with the standard curve obtained from pure nucleoside standards running on the same batch of samples. The ratio of m 6 A to A was calculated based on the calibrated concentrations, and data was normalized to control samples.
mRNA-seq
PolyA+ RNA was isolated from the striata of 3 mice per group mice as described above. mRNA was further purified using RiboMinus Eukaryote Kit v2 (Invitrogen). Around 15 ng purified mRNA from an individual mouse was used for library construction using TruSeq stranded mRNA library prep kit (Illumina) according to manufacturer's protocol. Sequencing was carried out on Illumina HiSeq 4000 according to the manufacturer's instructions. A-seq PolyA+ RNA was isolated from mice striata as described above. RNA fragmentation was performed by sonication at 10 ng/ml in 100 mL RNase-free water using Bioruptor Pico (Diagenode) with 30 s on/30 s off for 30 cycles. m 6 A-IP and library preparation were performed according to the previous protocol (Dominissini et al., 2013) . Specifically, RNA from three mice were pooled together as one replicate. 5 mL 0.5 mg/ml rabbit polyclonal m 6 A antibody (Synaptic Systems Cat# 202-203, RRID: AB_2279214) and 20 ml . Brains were rapidly removed and 250 mm striatal slices were cut in cold ACSF using a vibratome (Leica VT1000 S). Slices were transferred to 32 C oxygenated ACSF for 12 minutes, then transferred to a perfusion holding chamber with room temperature (20-22 C) oxygenated ACSF containing (in mM): 92 NaCl, 2.5 KCl, 1.2 NaH 2 PO 4 , 30 NaHCO 3 , 25 glucose, 12 N-acetyl-L-cysteine, 20 HEPES, 5 sodium ascorbate, 2 thiourea, 3 sodium pyruvate, 2 MgSO 4 (7H 2 O), and 2 CaCl 2 (pH 7.3 with NaOH). Slices were incubated for at least 60 min before recording.
Electrophysiology whole-cell patch clamp recording Slices were perfused at 2 mL/min at room temperature with oxygenated ACSF containing (in mM): 125 NaCl, 2.5 KCl, 1 MgCl 2 (6H 2 O), 2.5 CaCl 2 , 20 glucose, 1 NaH 2 PO 4 , 25 NaHCO 3 . All experiments were carried out in the presence of 50 mM picrotoxin. Dorsal striatal MSNs expressing mCherry were identified with epifluorescence microscopy on an upright microscope (Olympus BX51W1). Recordings were made with borosilicate glass patch electrodes (3-7 MU) filled with internal solution containing (in mM): 130 K-gluconate, 3 KCl, 0.5 EGTA, 10 HEPES, 10 glucose, 3 MgCl 2 , 4 ATP, 0.3 GTP, and 0.1% w/v biocytin (290 mOsm, pH 7.3 with KOH). Current-and voltage-clamp data were obtained with a MultiClamp 700B amplifier, digitized with a Digidata 1440A digitizer, and viewed with Axon pCLAMP v10.6.2.2 software (Molecular Devices). Signals were digitized at 10 kHz and filtered at 4 kHz. Holding potential was À80 mV, and series resistance (< 25MU) was continuous monitored throughout recording with a 10 mV depolarizing step. Experiments were discarded if the series resistance varied by more than 20%. Synaptic currents were evoked by a 200 ms pulse delivered by Master-8 pulse stimulator (A.M.P.I.) through a bipolar tungsten electrode placed within the striatum dorsolateral to the site of recording. Paired-pulse ratio (PPR) was calculated by dividing the second evoked EPSC by the first with a 50-ms inter-stimulus interval. Capacitance was calculated by the pCLAMP 10 software. Input resistance was measured with a À50 pA hyperpolarizing step. Rheobase current, I-V curves, and F-I curves were measured in current clamp by applying 1500 ms current pulses ranging from À200 pA to 400 pA with 25 pA increment steps every 10 s. Post recording, lack or presence of METTL14 in biocytin (AnaSpec) filled cells was confirmed.
Dendritic spine morphology
For viral mCherry spine analysis, 250 mm sections were submerged in cold formalin over-night and later held in PBS at 4 C. When ready for processing, sections were washed 3 times in PBS for 5 minutes, 3 times in PBS with Triton-X 1% for 5 minutes and an additional 3 times in PBS for 5 minutes. Slices were mounted in Gelvatol medium between two coverslips (Thermo). Imaging and analysis was performed by an analyst blind to the experimental conditions. Second and third order dendrites were imaged with an SP5 Leica confocal under a 63x oil lens with a resolution of 0.074 mm x 0.074 mm x 0.130 mm. Seven dendrites, one dendrite per neuron, were imaged for each animal.
After acquisition, images were deconvolved using Huygens Professional software using classic maximum likelihood estimations (Scientific Volume Imaging). Images were imported into Imaris 9.0 (Bitplane), a segment 50 À75 mm away from the soma was cropped to a length of 10 mm and filtered for artifacts and axons. The Imaris Filament Tracer was used to reconstruct each dendritic segment. The Shortest Distance from Distance Map algorithm was used for dendrite and spine diameter thresholding. Imaris detected potential spines and seed point were inspected and manually adjusted for corrections. Data was exported and finally compiled by a different experimenter.
Sholl analysis 250 mm brain sections containing biocytin filled mCherry expressing D1-MSNs were fixed in formalin and then held in PBS at 4 C. Sections were blocked in TBS containing 5% normal donkey serum, 0.5% Triton-X, and 1% BSA for 1 hour at room temperature, transferred to streptavidin-488 (Invitrogen; Bill's antibody) in blocking solution, and incubated for 3 hours at room temperature. The biocytin-filled neurons were imaged using a Leica SP5 confocal microscope with a 20x objective and 1.01 mm step size to capture the entire dendritic trees. Image stacks were manually traced and collapsed to 2D images using maximum intensity projection, which were thresholded to create 8-bit binary images in FIJI (Schindelin et al., 2012) . Sholl analysis was performed using FIJI (Ferreira 
